EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Prevalence and burden of chronic kidney disease-associated pruritus in Europe (CENSUS-EU)

James O Burton iD, Maurizio A Gallieni iD, Stefan H Jacobson, Pablo Molina, Timm H Westhoff, Amandine Perrin, Despina Ruessmann

Journal of Nephrology · 2026

DOI: 10.1093/joneph/aajag038 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Nephrology, 2026. Verfasst von James O Burton und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom. Hauptthemen laut MEDLINE: Pruritus, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vifor Fresenius Medical Care Renal Pharma Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease-associated pruritus (CKD-aP) is associated with poor health-related quality of life (HRQoL). However, clarity on its prevalence is lacking. CENSUS-EU was a real-world, cross-sectional, non-interventional, multicentre study carried out in seven European countries to assess the prevalence of CKD-aP and its impact on HRQoL in patients receiving haemodialysis (HD).

Methods

Patients aged ≥18 years with CKD who were receiving in-centre HD for ≥3 months were eligible for enrolment. Medical records were used to gather baseline demographics and clinical characteristics. Patients completed patient-reported outcomes on pruritus severity (the Worst Itching Intensity Numerical Rating Scale) and HRQoL. They also completed a questionnaire on pruritus communication and treatment. Data were analysed by pruritus severity.

Results

Of 3095 enrolled patients, data concerning 2963 were available for analysis. Mean age was 66.2 years, and 62.7% were male. The prevalence of CKD-aP was 53.5%; 22.3% of patients experienced mild, 18.0% moderate, and 13.2% severe pruritus. Patients with moderate-to-severe pruritus experienced greater difficulty sleeping, higher depression scores, greater disability, and impact on daily activities compared with patients with no pruritus (P < .0001, all comparisons). Patients mainly reported pruritus to nephrologists (49%) or dialysis nurses (33.8%). However, 26.2% of patients experiencing pruritus did not report it to anyone, and 40.9% of patients with current or past severe itch were untreated at the time of study visit.

Conclusions

In this study, over half of patients experienced CKD-aP, with 31.2% reporting moderate or severe symptoms. Many patients were untreated despite experiencing itch that impacted their HRQoL and day-to-day activities. Clinical Trial Registration This study was registered at ClinicalTrials.gov (Identifier: NCT05524467).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PruritusRenal Insufficiency, ChronicHumansMaleFemaleAgedPrevalenceEuropeCross-Sectional StudiesMiddle AgedQuality of LifeSeverity of Illness IndexRenal DialysisSymptom BurdenCost of IllnessAged, 80 and overPatient Reported Outcome MeasuresAdult

Stichwörter der Autor:innen

chronic kidney disease-associated pruritushealth-related quality of lifepatient-reported outcomesprevalence

Autor:innen und Institutionen

  • Department of Cardiovascular Sciences, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
  • Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
  • Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
  • Department of Nephrology, Hospital Universitari i Politècnic La Fe, University of Valencia, Valencia, Spain.
  • Department of Nephrology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany.
  • CSL Vifor, Glattbrugg, Switzerland.

ORCID-Profile: James O Burton, Maurizio A Gallieni

Förderung

  • Vifor Fresenius Medical Care Renal Pharma Ltd

Zitieren

APA

Burton, J. O., Gallieni, M. A., Jacobson, S. H., Molina, P., Westhoff, T. H., Perrin, A., & Ruessmann, D. (2026). Prevalence and burden of chronic kidney disease-associated pruritus in Europe (CENSUS-EU). Journal of Nephrology. https://doi.org/10.1093/joneph/aajag038

Vancouver

Burton JO, Gallieni MA, Jacobson SH, Molina P, Westhoff TH, Perrin A, et al. Prevalence and burden of chronic kidney disease-associated pruritus in Europe (CENSUS-EU). Journal of Nephrology. 2026. doi:10.1093/joneph/aajag038

BibTeX
@article{Burton2026,
  author = {Burton, James O and Gallieni, Maurizio A and Jacobson, Stefan H and Molina, Pablo and Westhoff, Timm H and Perrin, Amandine and Ruessmann, Despina},
  title = {Prevalence and burden of chronic kidney disease-associated pruritus in Europe (CENSUS-EU)},
  journal = {Journal of Nephrology},
  year = {2026},
  doi = {10.1093/joneph/aajag038}
}
Kostenlos starten →